Speakers
Ranajoy Majumdar
Director – Analytical Development
Eli Lilly & Company
Day One
Wednesday, August 31 2022
11:45 am | Roundtable - Role of Characterization Techniques in Formulation & Analytical Development of Small Oligonucleotides
Oliver Thiel
Executive Director Process Development, Drug Substance Technologies Pivotal & Commercial Synthetics
Amgen
Day Two
Thursday, September 1 2022
9:45 am | Roundtable Discussion: Sustainable Manufacturing & Novel Green Chemistry Approach
Rob Shaffer
Founder/COO
Vrata Therapeutics
Day One
Wednesday, August 31 2022
3:30 pm | Emerging Formulation Strategies to Improve Oligonucleotide PK & Delivery to Extra-Hepatic Tissues
Day Two
Thursday, September 1 2022
4:00 pm | 4:00pm | Chair’s Closing Remarks & End of Summit
8:50 am | Chair’s Opening Remarks
Ashish Garg
Director of Engineering
Eli Lilly & Company
Day One
Wednesday, August 31 2022
2:00 pm | Selection of Isolation Process for Drug Substance for Peptides & Oligonucleotides Using a Six-Sigma Approach
Bob Duff
Senior Director, Medicine Chemistry
Switch Therapeutics
Day Two
Thursday, September 1 2022
10:15 am | Exploring Attributes & Analytics
Tim Turner
Senior Manager, Synthetic Process Development
Alexion Pharmaceuticals
Day One
Wednesday, August 31 2022
4:30 pm | 4:30pm | Chair’s Closing Remarks & End of Day One
We look forward to welcoming you back for Day Two!
We look forward to welcoming you back for Day Two!
9:20 am | Chair’s Opening Remarks
Day Two
Thursday, September 1 2022
11:45 am | Roundtable Discussion: Reducing the Waste in Oligo Synthesis
Michael Hellerstein
VP Product Development
Vaxxinity
Day Two
Thursday, September 1 2022
1:30 pm | Successful Partnering in Tech Transfer to CROs & CDMOs
Prof Dimitrios A. Lamprou
Professor
Queens University Belfast
Day Two
Thursday, September 1 2022
11:15 am | Emerging Technologies for Biopharma Manufacturing
Zhongping Liao
Sr. Advisor
Eli Lilly & Company
Day Two
Thursday, September 1 2022
2:00 pm | Mass Spectrometry Characterization of siRNA-Antibody Conjugates
Rajendra K Pandey
Vice President, Chemistry
Cargene Therapeutics
Day Two
Thursday, September 1 2022
9:00 am | Exploring Solid Phase Synthesis of Oligos & Post-Synthesis Conjugation
Laure-Elie Carloni
Associate Director
Janssen Pharmaceuticals
Day One
Wednesday, August 31 2022
1:30 pm | It’s Not an Afterthought – The Role of Analytics in Formulation & Process Development
Nigel Richardson
Technical Director
CatSci Ltd
Gordon Lambertus
Principal Research Scientist
Eli Lilly & Company
Day Two
Thursday, September 1 2022
3:30 pm | Understanding Emerging Technology Development in Peptides
Tomas Leek
Director
AstraZeneca
Day One
Wednesday, August 31 2022
4:00 pm | Challenges in Early phase Analytics & Characterization of Synthetic Macromolecules
Naresh Badgujar
Associate Principal Scientist
AstraZeneca
Day One
Wednesday, August 31 2022
2:30 pm | Exploring the Challenges of Oligonucleotide Chemistry
Marc Lemaitre
Principal
ML Consult
Day One
Wednesday, August 31 2022
9:30 am | CMC for cGMP Manufacturing of Oligonucleotides
Mike Webb
Founder & CEO
Mike Webb Pharma
Day Two
Thursday, September 1 2022
3:00 pm | Developing Analytical Control Strategies for Therapeutic Oligonucleotides
Liping Zhou
Senior Director, Advanced Drug Delivery
AstraZeneca
Lu Tian
Director, CMC Project Management
STA Pharmaceutical
Day One
Wednesday, August 31 2022
10:00 am | Outlining Oligo Drug Delivery & LNP Platform at WuXi STA
Frank Shlafer
Process Engineer, Technology & Innovation Group
Nitto Avecia
Day Two
Thursday, September 1 2022
9:30 am | Synthesis Optimization by PAT
Kris Iyer
Chief Scientific Officer
RIGImmune Inc
Hagen Cramer
Chief Production Officer
QurAlis